Table 4.
Circulating long-chain acylcarnitine concentrations and resting energy metabolism measures after combining exercise and control groups at 12 wk and 36 wk gestation in sedentary women with obesity
| 12 Wk | 36 Wk | P | |
|---|---|---|---|
| C14, µmol/L | 0.021 (0.001) | 0.017 (0.001) | <0.001 |
| C16, µmol/L | 0.113 (0.002) | 0.092 (0.002) | <0.001 |
| C18:1, µmol/L | 0.237 (0.006) | 0.185 (0.006) | <0.001 |
| C18:2, µmol/L | 0.253 (0.005) | 0.206 (0.005) | <0.001 |
| V̇o2, mL/kg/min | 2.82 (0.392) | 3.02 (0.510) | 0.010 |
| V̇o2, mL/kg FFM/min | 5.51 (0.711) | 5.69 (1.13) | 0.243 |
| REE, kcal/kg/day | 19.66 (0.37) | 21.07 (0.38) | 0.008 |
| REE, kcal/kg FFM/day | 38.36 (0.76) | 39.69 (0.78) | 0.221 |
| RER | 0.813 (0.006) | 0.819 (0.006) | 0.503 |
Values in the table are means and (standard deviations). A one-factor analysis of covariance (factor: week) was run after combining groups. Bold values represent statistical significance. Serum samples were used to quantify acylcarnitines (ACs). Indirect calorimetry was used to measure V̇o2, REE, and RER. C14, myristoylcarnitine; C16, palmitoylcarnitine; C18:1, oleoylcarnitine; C18:2, linoleoylcarnitine; REE, resting energy expenditure; RER, respiratory exchange ratio; V̇o2, volume of oxygen uptake.